Changeflow GovPing Pharma & Drug Safety UV Absorbing System With Physical Material Colo...
Routine Notice Added Final

UV Absorbing System With Physical Material Coloring Agent

Favicon for changeflow.com USPTO Patent Applications - Pharma (A61K)
Published
Detected
Email

Summary

USPTO published L'OREAL's patent application (US20260096967A1) for UV-absorbing compositions containing physical UV-attenuating materials and coloring agents. The application covers methods of making and using such cosmetic compositions for sun protection. The application was filed October 3, 2025.

What changed

USPTO published L'OREAL's patent application for compositions containing a UV-absorbing system including physical UV-attenuating material and a coloring agent. The application (US20260096967A1) covers the compositions themselves as well as methods of making and using such compositions. Inventors include Brian Bodnar, Anil Shah, Widad Ajili, and Juliette Beiller.

Manufacturers and investors in the personal care and cosmetics industry should monitor this application for potential impacts on sun protection product development. While patent applications are informational and do not yet grant rights, successful issuance could affect competitive positioning in the UV protection market.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 9, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Coloring Agent

Application US20260096967A1 Kind: A1 Apr 09, 2026

Assignee

L'OREAL

Inventors

BRIAN BODNAR, ANIL SHAH, WIDAD AJILI, JULIETTE BEILLER

Abstract

The present disclosure relates to compositions including a UV absorbing system including at least one physical ultraviolet (UV)-attenuating material, and at least one coloring agent, as well as to methods of making and using such compositions.

CPC Classifications

A61K 8/27 A61K 8/062 A61K 8/26 A61K 8/29 A61K 8/31 A61K 8/37 A61K 8/585 A61Q 17/04 A61K 2800/30 A61K 2800/413 A61K 2800/43 A61K 2800/621 A61K 2800/622 A61K 2800/624 A61K 2800/651

Filing Date

2025-10-03

Application No.

19349335

View original document →

Get daily alerts for USPTO Patent Applications - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260096967A1

Who this affects

Applies to
Manufacturers Investors
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent filing UV protection products
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Consumer Protection

Get alerts for this source

We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.